| Date | Title | Description |
| 16.12.2025 | Valinor Secures $13 Million to Revolutionize Clinical Trials with AI | Valinor, a San Francisco-based AI firm, just raised $13 million. This seed funding aims to improve clinical trial success. The company uses machine learning. It analyzes patient data to predict treatment response. This reduces trial failure... |
| 16.12.2025 | AI Firm Valinor Secures $13M to Revolutionize Clinical Trials | Valinor, a San Francisco-based AI company, just raised $13 million in seed funding. The company aims to drastically improve clinical trial success rates. It uses AI to predict patient response to drugs *before* trials begin. This “response-... |
| 12.12.2025 | Valinor Raises $13M in Funding | Valinor, a San Francisco, CA-based AI company leveraging machine learning models to increase the probability of clinical trial success, raised $13M in Seed funding.
The round was led by CRV, Harpoon Ventures, Amino Collective, and Pelion Ve... |
| 11.12.2025 | Valinor Raises $13M to Predict Clinical Trial Outcomes Using Multi-Omic AI | What You Should Know:
– Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry’s most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures.
– The company uses proprietary AI model... |
| - | Valinor Discovery | “Valinor | Machine Learning to Accelerate Clinical Drug Development” |
